Y-MABS THERAPEUTICS, INC. (a Delaware corporation) 2,439,025 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 19th, 2021 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 19th, 2021 Company Industry Jurisdiction
ASSET PURCHASE AGREEMENT BY AND BETWEEN UNITED THERAPEUTICS CORPORATION AND Y-MABS THERAPEUTICS, INC. December 24, 2020Asset Purchase Agreement • February 19th, 2021 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 24, 2020 (“Effective Date”), by and between United Therapeutics Corporation, a Delaware corporation (“Buyer”), and Y-mAbs Therapeutics, Inc., a Delaware corporation (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.